Results 131 to 140 of about 4,151 (165)
Some of the next articles are maybe not open access.

Dutasteride

Drugs, 2008
Dutasteride (Avodart), an oral synthetic 4-azasteroid, is a potent, selective, irreversible inhibitor of type 1 and type 2 5alpha-reductase (5AR), the enzyme that converts testosterone to dihydrotestosterone (DHT) intracellularly. Although type 2 5AR predominates, both isoenzymes are overexpressed in prostate tissue in benign prostatic hyperplasia (BPH)
Susan J, Keam, Lesley J, Scott
openaire   +2 more sources

Dutasteride

Reactions Weekly, 2021
openaire   +2 more sources

Dutasteride/Tamsulosin

Drugs & Aging, 2012
The 5α-reductase inhibitor dutasteride and the α(1)-adrenergic receptor antagonist tamsulosin are available as a fixed-dose combination for use in men with symptomatic benign prostatic hyperplasia (BPH) and an enlarged prostate. Dutasteride 0.5 mg/day plus tamsulosin 0.4 mg/day improved lower urinary tract symptoms (LUTS) to a significantly greater ...
openaire   +2 more sources

Dutasteride and Prostate Cancer Risk

Current Urology Reports, 2010
In a previously published and heavily discussed paper [1], the type 2 5-α-reductase inhibitor (5ARI) finasteride was shown to reduce the risk of prostate cancer by a substantial 25% as compared to placebo in men at no known risk of developing prostate cancer.
openaire   +2 more sources

Dutasteride

Drugs of the Future, 1999
null Graul, A.   +2 more
openaire   +1 more source

Dutasteride

Reactions Weekly, 2007
openaire   +1 more source

Dutasteride

Reactions Weekly, 2019
openaire   +1 more source

Home - About - Disclaimer - Privacy